Megan W. France, Mary E. Dodd, John R. Govan, Catherine J. Doherty, A

Slides:

Advertisements

Similar presentations

Long-term non-invasive ventilation in cystic fibrosis — Experience over two decades William G. Flight, Jonathan Shaw, Susan Johnson, A. Kevin Webb, Andrew.

Advertisements

Use of the insulin pump in treat cystic fibrosis related diabetes Dana S. Hardin, Julie Rice, Mark Rice, Randall Rosenblatt Journal of Cystic Fibrosis.

Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis Giuseppe Valenza, Dennis Tappe, Doris.

ARFI and transient elastography for characterization of cystic fibrosis related liver disease: First longitudinal follow-up data in adult patients Thomas.

Cheryl Cameron, Mark W. Lodes, William M. Gershan

The prevalence of “risky behaviour” in adults with cystic fibrosis

Rapid emergence of a ceftazidime-resistant Burkholderia multivorans strain in a Cystic Fibrosis patient Joshua R. Stokell, Raad Z. Gharaibeh, Todd R.

Treatment compliance in children and adults with Cystic Fibrosis

Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex Yury Herasimenka, Paola Cescutti, Giuseppe Impallomeni,

Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center

Development, validation, and implementation of a questionnaire assessing disease knowledge and understanding in adult cystic fibrosis patients Karen.

Cystic fibrosis research in allied health and nursing professions

William G. Flight, Jonathan Shaw, Susan Johnson, A

K. L. Nash, M. E. Allison, D. McKeon, D. J. Lomas, C. S. Haworth, D

Heleen Van Acker, Elisabeth Van Snick, Hans J. Nelis, Tom Coenye

R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J

PCR detection of Burkholderia cepacia complex as one of key factors to handle a long- term outbreak Klara Dedeckova, Libor Fila, Veronika Skalicka, Jana.

Novel diagnostic PCR assay for Burkholderia cenocepacia epidemic strain ST32 and its utility in monitoring infection in cystic fibrosis patients Klara.

Abaigeal D. Jackson, Christopher H. Goss Journal of Cystic Fibrosis

ARFI and transient elastography for characterization of cystic fibrosis related liver disease: First longitudinal follow-up data in adult patients Thomas.

Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H

Megan R. Nelson, Craig R. Adamski, Audrey Tluczek

Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands R.W. Brimicombe, L. Dijkshoorn, T.J.K.

Urinary incontinence in 9��16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group W.J. Browne, C.J. Wood, M.

Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study Doug L. Forrester, Alan J. Knox,

Genomovar status, virulence markers and genotyping of Burkholderia cepacia complex strains isolated from Brazilian cystic fibrosis patients Kátia Maia.

Laura Viviani, Baroukh M. Assael, Eitan Kerem

Cirrhosis and other liver disease in cystic fibrosis

Controlled clinical trials in cystic fibrosis — are we doing better?

Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study Christine Rønne.

Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar

D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams

Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox

Controversies with Kalydeco: Newspaper coverage in Canada and the United States of the cystic fibrosis “wonder drug” Christen Rachul, Maeghan Toews,

Gerd Döring, Patrick Flume, Harry Heijerman, J. Stuart Elborn

The Journal of Cystic Fibrosis: Sunny perspectives

Kellie J. Goodlet, Michael D. Nailor, Ashraf Omar, Jasmine L

A.H. Gifford Journal of Cystic Fibrosis

Demographics of glucose metabolism in cystic fibrosis

Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden Per Kristian Knudsen, Hanne.

Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis Sanja Stanojevic, Valerie Waters, Joseph L.

Cystic fibrosis related diabetes in an extremely young patient

E. Tschiedel, H. Grasemann, F. Ratjen Journal of Cystic Fibrosis

Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?

Transient isolation of Burkholderia multivorans and Burkholderia cenocepacia from a Brazilian cystic fibrosis patient chronically colonized with Burkholderia.

Anastasios Lekkas, Khin M. Gyi, Margaret E. Hodson

Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis Christopher R. Sudfeld, Elliott C. Dasenbrook, William.

Inflammatory and immunological biomarkers are not related to survival in adults with Cystic Fibrosis K.L. Moffitt, S.L. Martin, A.M. Jones, A.K. Webb,

Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis Geraint B. Rogers, Lucas R. Hoffman,

Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic Amanda L. Griffiths, Danielle F. Wurzel,

Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire Joän M. Patterson, Melanie Wall, Jerica.

Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005 F.A. Millar, N.J. Simmonds, M.E. Hodson Journal.

Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids Francis J. Gilchrist, A.

V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume

H. White, A.M. Morton, S.P. Conway, D.G. Peckham

J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer

Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis Giuseppe Valenza, Dennis Tappe, Doris.

D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher

The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation C. Etherington,

CFTR modulators and pregnancy: Our work has only just begun

Patient segregation and aggressive antibiotic eradication therapy can control methicillin- resistant Staphylococcus aureus at large cystic fibrosis centres

Beta-lactam allergy in adults with cystic fibrosis

Cheryl Cameron, Mark W. Lodes, William M. Gershan

Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub

David Adeboyeku, Sandra Scott, Margaret E. Hodson

Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern?

Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L

Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis D.J. Touw, A.J. Knox,

Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience C.R.

H. White, A.M. Morton, D.G. Peckham, S.P. Conway

Presentation transcript:

The changing epidemiology of Burkholderia species infection at an adult cystic fibrosis centre Megan W. France, Mary E. Dodd, John R. Govan, Catherine J. Doherty, A.K. Webb, Andrew M. Jones Journal of Cystic Fibrosis Volume 7, Issue 5, Pages 368-372 (September 2008) DOI: 10.1016/j.jcf.2008.01.002 Copyright © 2008 Terms and Conditions

Fig. 1 Incidence and prevalence of B. cepacia complex infection at the Manchester Adult Cystic Fibrosis Centre, 1983–2006. Journal of Cystic Fibrosis 2008 7, 368-372DOI: (10.1016/j.jcf.2008.01.002) Copyright © 2008 Terms and Conditions

Fig. 2 Incidence of transmissible and unique strains of B. cepacia complex infection at the centre, 1983–2006. Journal of Cystic Fibrosis 2008 7, 368-372DOI: (10.1016/j.jcf.2008.01.002) Copyright © 2008 Terms and Conditions

Fig. 3 Prevalence of transmissible and unique strains of B. cepacia complex infection at the centre, 1983–2006. Journal of Cystic Fibrosis 2008 7, 368-372DOI: (10.1016/j.jcf.2008.01.002) Copyright © 2008 Terms and Conditions

Fig. 4 New infection amongst established patients at the centre, 1991–2006. Journal of Cystic Fibrosis 2008 7, 368-372DOI: (10.1016/j.jcf.2008.01.002) Copyright © 2008 Terms and Conditions